Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1980 Apr 5;122(7):765–769.

Fusidic acid: new opportunities with an old antibiotic.

J D Anderson
PMCID: PMC1801889  PMID: 6988070

Abstract

The extensive foreign experience with fusidic acid prior to its belated introduction to Canada is reviewed. Fusidic acid is a steroid antibiotic with minimal toxic and hormonal effects that is mainly excreted through the liver. It has a predominantly bactericidal action and does not shown cross-resistance with other antibiotics. Since organisms resistant to this drug form easily in vitro when exposed to low concentrations, complementary treatment with another antibiotic may be required in some clinical situations. Although fusidic acid is active in vitro against a number of organisms, to date it has mainly been used to treat serious infections due to Staphylococcus aureus. The agent appears to be particularly valuable in the treatment of bone and joint infections and in pediatric practice. Fusidic acid will soon be available in Canada for both oral and intravenous administration. Attainable antibiotic levels in many tissues and body fluids greatly exceed the minimum inhibitory concentrations.

Full text

PDF
765

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARBER M., WATERWORTH P. M. Antibacterial activity in vitro of fucidin. Lancet. 1962 May 5;1(7236):931–932. doi: 10.1016/s0140-6736(62)91969-4. [DOI] [PubMed] [Google Scholar]
  2. Black W. A., McNellis D. A. Comparative in-vitro sensitivity of Nocardia species to fusidic acid and sulphonamides. J Med Microbiol. 1971 May;4(2):293–295. doi: 10.1099/00222615-4-2-293. [DOI] [PubMed] [Google Scholar]
  3. Blockey N. J., McAllister T. A. Antibiotics in acute osteomyelitis in children. J Bone Joint Surg Br. 1972 May;54(2):299–309. [PubMed] [Google Scholar]
  4. CROSBIE R. B. Treatment of staphylococcal infections with "fucidin". Br Med J. 1963 Mar 23;1(5333):788–794. doi: 10.1136/bmj.1.5333.788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chadwick A. J., Jackson B. Intraocular penetration of the antibiotic fucidin. Br J Ophthalmol. 1969 Jan;53(1):26–29. doi: 10.1136/bjo.53.1.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chater E. H., Flynn J., Wilson A. L. Fucidin levels in osteomyelitis. J Ir Med Assoc. 1972 Oct 21;65(20):506–508. [PubMed] [Google Scholar]
  7. Deodhar S. D., Russell F., Dick W. C., Nuki G., Buchanan W. W. Penetration of sodium fusidate (Fucidin) in the synovial cavity. Scand J Rheumatol. 1972;1(1):33–39. doi: 10.3109/03009747209102991. [DOI] [PubMed] [Google Scholar]
  8. Evans R. J., Waterworth P. M. Naturally-occurring fusidic acid resistance in staphylococci and its linkage to other resistances. J Clin Pathol. 1966 Nov;19(6):555–560. doi: 10.1136/jcp.19.6.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. GODTFREDSEN W., ROHOLT K., TYBRING L. Fucidin: a new orally active antibiotic. Lancet. 1962 May 5;1(7236):928–931. doi: 10.1016/s0140-6736(62)91968-2. [DOI] [PubMed] [Google Scholar]
  10. Gray I. R. The choice of antibiotic for treating infective endocarditis. Q J Med. 1975 Jul;44(175):449–458. [PubMed] [Google Scholar]
  11. Güttler F., Tybring L., Engberg-Pedersen H. Interaction of albumin and fusidic acid. Br J Pharmacol. 1971 Sep;43(1):151–160. doi: 10.1111/j.1476-5381.1971.tb07164.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Harvey C. L., Knight S. G., Sih C. J. On the mode of action of fusidic acid. Biochemistry. 1966 Oct;5(10):3320–3327. doi: 10.1021/bi00874a034. [DOI] [PubMed] [Google Scholar]
  13. Hierholzer G., Rehn J., Knothe H., Masterson J. Antibiotic therapy of chronic post-traumatic osteomyelitis. J Bone Joint Surg Br. 1974 Nov;56-B(4):721–729. doi: 10.1302/0301-620X.56B4.721. [DOI] [PubMed] [Google Scholar]
  14. JENSEN K. A., KLER I. FUCIDIN. A STUDY ON PROBLEMS OF RESISTANCE. I. Acta Pathol Microbiol Scand. 1964;60:271–284. doi: 10.1111/apm.1964.60.2.271. [DOI] [PubMed] [Google Scholar]
  15. Jensen K., Lassen H. C. Combined treatment with antibacterial chemotherapeutical agents in staphylococcal infections. Q J Med. 1969 Jan;38(149):91–106. [PubMed] [Google Scholar]
  16. Kanski J. J. Treatment of late endophthalmitis associated with filtering blebs. Arch Ophthalmol. 1974 May;91(5):339–343. doi: 10.1001/archopht.1974.03900060351001. [DOI] [PubMed] [Google Scholar]
  17. LOWBURY E. J., JACKSON D. M., CASON J. S., MILLER R. W. Fucidin for staphylococcal infection of burns. Lancet. 1962 Sep 8;2(7254):478–480. doi: 10.1016/s0140-6736(62)90339-2. [DOI] [PubMed] [Google Scholar]
  18. Lauen O. Mastitis acuta puerperalis behandlet med Fucidin. Tidsskr Nor Laegeforen. 1969 Jun 1;89(11):816–819. [PubMed] [Google Scholar]
  19. Leigh D. A. Clinical importance of infections due to Bacteroides fragilis and role of antibiotic therapy. Br Med J. 1974 Jul 27;3(5925):225–228. doi: 10.1136/bmj.3.5925.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Menday A. P., Marsh B. T. Intravenous fusidic acid ('Fucidin') in the management of severe staphylococcal infections: a review of 46 cases. Curr Med Res Opin. 1976;4(2):132–138. doi: 10.1185/03007997609109293. [DOI] [PubMed] [Google Scholar]
  21. Miles R. S., Moyes A. Comparison of susceptibility of Neisseria meningitidis to sodium sulphadiazine and sodium fusidate in vitro. J Clin Pathol. 1978 Apr;31(4):355–358. doi: 10.1136/jcp.31.4.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Moore J. R. Purpura after warfarin. Lancet. 1967 Sep 2;2(7514):516–516. doi: 10.1016/s0140-6736(67)91695-9. [DOI] [PubMed] [Google Scholar]
  23. NEWMAN R. L., BHAT K. M., HACKNEY R., ROBINSON C., STEWART G. T. Fusidic acid: laboratory and clinical assessment. Br Med J. 1962 Dec 22;2(5320):1645–1647. doi: 10.1136/bmj.2.5320.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. NIELSEN J. [Fucidin. Preliminary trials in a general surgical department]. Ugeskr Laeger. 1962 Jun 1;124:837–841. [PubMed] [Google Scholar]
  25. O'Grady F., Greenwood D. Interactions between fusidic acid and penicillins. J Med Microbiol. 1973 Nov;6(4):441–450. doi: 10.1099/00222615-6-4-441. [DOI] [PubMed] [Google Scholar]
  26. Oakley C. Use of antibiotics. Endocarditis. Br Med J. 1978 Aug 12;2(6135):489–490. doi: 10.1136/bmj.2.6135.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rowling D. E., Kirkcaldy Further experience in the management of chronic osteomyelitis. J Bone Joint Surg Br. 1970 May;52(2):302–307. [PubMed] [Google Scholar]
  28. Sorensen B., Sejrsen P., Thomsen M. Fucidin, pro-staphlin, and penicillin concentration in burn crusts. Acta Chir Scand. 1966 Jun;131(6):423–429. [PubMed] [Google Scholar]
  29. Stirling J., Goodwin S. Susceptibility Bacteroides fragilis to fusidic acid. J Antimicrob Chemother. 1977 Sep;3(5):522–523. doi: 10.1093/jac/3.5.522. [DOI] [PubMed] [Google Scholar]
  30. TAYLOR G., BLOOR K. Antistaphylococcal activity of fucidin. Lancet. 1962 May 5;1(7236):935–937. doi: 10.1016/s0140-6736(62)91972-4. [DOI] [PubMed] [Google Scholar]
  31. WYNN V. METABOLIC EFFECTS OF THE STEROID ANTIBIOTIC FUSIDIC ACID. Br Med J. 1965 May 29;1(5447):1400–1404. doi: 10.1136/bmj.1.5447.1400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Williamson J., Russell F., Doig W. M., Paterson R. W. Estimation of sodium fusidate levels in human serum, aqueous humour, and vitreous body. Br J Ophthalmol. 1970 Feb;54(2):126–130. doi: 10.1136/bjo.54.2.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wright G. L., Harper J. Fusidic acid and lincomycin therapy in staphylococcal infections in cystic fibrosis. Lancet. 1970 Jan 3;1(7636):9–14. doi: 10.1016/s0140-6736(70)90523-4. [DOI] [PubMed] [Google Scholar]
  34. de Louvois J., Gortvai P., Hurley R. Antibiotic treatment of abscesses of the central nervous system. Br Med J. 1977 Oct 15;2(6093):985–987. doi: 10.1136/bmj.2.6093.985. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES